Loxo Oncology In Shares Up 16.5% Since SmarTrend's Buy Recommendation (LOXO)

SmarTrend identified an Uptrend for Loxo Oncology In (NASDAQ:LOXO) on December 8th, 2017 at $82.68. In approximately 2 months, Loxo Oncology In has returned 16.46% as of today's recent...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.